Insights into the genomics of multiple myeloma - new drug targets and when to do a genomic analysis
The importance of the microenvironment in multiple myeloma
Prospective targeted therapies for multiple myeloma
Is FISH becoming obsolete in multiple myeloma?
Why patients should be involved in evaluating novel drugs in multiple myeloma